Hyperion Defi, Inc. Stock: price and insider trades · United States

This page follows insider dealings at Hyperion Defi, Inc. as filed with SEC (Form 4), a company from the Health Care sector. In the past year (21 October 2025 to 21 October 2026), 10 filings came from 6 insiders.

Only purchases show up on the open market, 5 purchases in all worth €383k, filed by 4 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 3 senior executives and 1 finance chief. One trade stands out by size: a purchase of €159k from Walters Happy David, disclosed on 19 December 2025.

Compared with its exchange (5,454 companies, median 22 filings), a count of 10 filings is below the norm. Since 2018, the database holds 85 purchases and 5 sales by insiders of the company. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 813,455 USD and net income at -45.3 m USD.

In the case of 5 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The most recent open-market purchase was published on 5 January 2026, 289 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4.

In the same sector, recent insider purchases at Xenon Pharmaceuticals Inc. and Vivos Inc also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.